{{Drugbox
| Verifiedfields =
| Watchedfields =
| verifiedrevid =
| IUPAC_name = ''N''-Methyl-1-(naphthalen-2-yl)propan-2-amine
| image = Methamnetamine_structure.png
| width = 200px

<!--Clinical data-->
| tradename = 
| pregnancy_category =
| legal_status = Illegal in Japan
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref =
| CAS_number =
| ATC_prefix =
| ATC_suffix =
| PubChem = 17802040
| ChemSpiderID_Ref =
| ChemSpiderID = 38754167

<!--Chemical data-->
| C=14 | H=17 | N=1
| molecular_weight = 
| smiles = CNC(C)Cc1ccc2ccccc2c1
| StdInChI = 1S/C14H17N/c1-11(15-2)9-12-7-8-13-5-3-4-6-14(13)10-12/h3-8,10-11,15H,9H2,1-2H3
| StdInChIKey = BWWWOLYZMKACSB-UHFFFAOYSA-N
}}

'''Methamnetamine''' (also known as '''methylnaphetamine''', '''MNA''', '''MNT''' and '''PAL-1046''') is a [[serotonin-norepinephrine-dopamine releasing agent|triple monoamine releasing agent]] and ''N''-methyl [[structural analog|analog]] of the non-[[neurotoxic]] experimental drug [[naphthylaminopropane]] and the [[naphthalene]] analog of [[methamphetamine]].<ref name="Rothman">{{cite journal | title=Studies of the Biogenic Amine Transporters. 14. Identification of Low-Efficacy "Partial" Substrates for the Biogenic Amine Transporters |author1=Richard B. Rothman |author2=John S. Partilla |author3=Michael H. Baumann |author4=Catrissa Lightfoot-Siordia |author5=Bruce E. Blough | journal=The Journal of Pharmacology and Experimental Therapeutics |date=April 2012  | volume=341 | issue=1 | pages=251–262 | doi=10.1124/jpet.111.188946 | pmid=22271821 | pmc=3364510}}</ref> It has been sold online as a [[designer drug]].<ref>{{cite web | url=http://www.wedinos.org/db/materials/view/00704 | title=Methamnetamine | publisher=WEDINOS}}</ref><ref>{{cite web | url=http://nsddb.eu/substance/509/ | title=Methamnetamine | publisher=New Synthetic Drugs Database}}</ref>

It acts as a [[releasing agent]] of [[serotonin]], [[norepinephrine]], and [[dopamine]], with [[EC50|EC<sub>50</sub>]] values of 13 nM, 34 nM, and 10 nM, respectively.<ref name="Rothman"/>

==Legal status==
Methamnetamine is illegal in Japan.<ref>{{cite web | url=http://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/iyakuhin/yakubuturanyou/dl/meisho.pdf | title=指定薬物名称・構造式一覧（平成27年9月16日現在） | publisher=厚生労働省 | date=16 September 2015 | language=Japanese | accessdate=8 October 2015}}</ref>

== See also ==
* [[Naphthylaminopropane]]
* [[HDEP-28]]
* [[HDMP-28]]
* [[Naphyrone]]
* [[2β-Propanoyl-3β-(2-naphthyl)-tropane|WF-23]]

==References==
{{reflist|30em}}

{{Entactogens|state=expanded}}
{{Stimulants}}
{{Adrenergics}}
{{Dopaminergics}}
{{Serotonergics}}
{{Phenethylamines}}

[[Category:Methamphetamines]]
[[Category:Designer drugs]]
[[Category:Entactogens and empathogens]]
[[Category:Naphthalenes]]
[[Category:Serotonin receptor agonists]]
[[Category:Serotonin-norepinephrine-dopamine releasing agents]]
[[Category:Stimulants]]


{{nervous-system-drug-stub}}